AI-Powered Precision Oncology Platform
Perthera (perthera.com) earns a Brand Analyzer score of 76 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 4481 Healthcare brands analyzed, Perthera ranks in the 59th percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 93/100, Digital Presence 100/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 87/100, AI Discoverability 82/100, Brand Authority 10/100.
Perthera, Inc. is a healthcare artificial intelligence company focused on precision oncology. It operates the Perthera Precision Oncology Platform, which combines multi-omic testing results with patient history and AI-enhanced real-world evidence to generate personalized, ranked cancer therapy recommendations. The company serves oncologists, cancer patients, healthcare providers, and research or pharmaceutical partners, positioning itself as a leader in AI-driven precision medicine aimed at improving clinical decision-making and supporting therapeutic innovation.
| Brand Name | Perthera |
|---|---|
| Domain | perthera.com |
| Industry | Healthcare, Technology |
| Main Competitors | Tempus (76/100), Foundation Medicine (73/100), Caris Life Sciences, SOPHiA GENETICS (87/100), Guardant Health (87/100), N-of-One (Qiagen) (88/100) |
Moz Domain Authority 27/100 vs category average 37 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Perthera, Inc., is the leading Healthcare Artificial Intelligence company advancing precision medicine through the Perthera Precision Oncology Platform." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Perthera scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Perthera has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 27/100. In a live check, Claude could already identify Perthera from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Perthera?", Claude could identify the brand as of August 2026. Perthera is a precision oncology company that provides data-driven treatment recommendations for cancer patients by integrating molecular tumor profiling, clinical data, and real-world outcomes analysis. It works with oncologists to match patients to targeted therapies and clinic Best known for Its molecular tumor board and precision medicine analytics platform that helps match cancer patients to personalized treatment options based on genomic testing .
When asked "Best brands similar to Perthera?", Claude would recommend Perthera as of August 2026. It's a notable player in precision oncology decision support, so I'd mention it if someone asked about companies helping match cancer patients to targeted therapies based on molecular profiling.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Perthera's main competitors include Tempus (76/100), Foundation Medicine (73/100), Caris Life Sciences, SOPHiA GENETICS (87/100), Guardant Health (87/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Perthera and N-of-One (Qiagen) are competitors in Healthcare. Brand Analyzer scores Perthera at 76/100 and N-of-One (Qiagen) at 88/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Perthera include Tempus (76/100), Foundation Medicine (73/100), Caris Life Sciences, SOPHiA GENETICS (87/100), Guardant Health (87/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Perthera offers the Perthera Precision Oncology Platform, an AI-powered service that combines multi-omic testing results with patient history and real-world evidence to deliver personalized, ranked cancer therapy recommendations for use by oncologists and healthcare providers.
Sources: Perthera official site
Perthera, Inc. is a healthcare artificial intelligence company that advances precision medicine through its Perthera Precision Oncology Platform, which is designed to match cancer patients with optimal, ranked therapy options.
Sources: Perthera official site
Perthera has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 33, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Perthera official site
Perthera combines multi-omic testing results with patient history and AI-enhanced real-world evidence to produce personalized, ranked cancer therapy recommendations. This is intended to accelerate clinical decision-making for oncologists and support therapeutic innovation for research and pharmaceutical partners.
Sources: Perthera official site
Perthera scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Perthera official site
Perthera's platform is used by oncologists, cancer patients, healthcare providers, and research and pharmaceutical partners seeking precision medicine solutions for cancer treatment.
Sources: Perthera official site
Perthera is known for its AI-driven precision oncology platform that integrates multi-omic data and patient history to generate ranked, personalized cancer treatment recommendations, positioning itself as a leading Healthcare Artificial Intelligence company in this space.
Sources: Perthera official site
Perthera can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Perthera official site
Ranked closest to Perthera: Pasito (76/100), Papa & Barkley (76/100), Petbarn (76/100), Pilat (76/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).